Podiatrists in Albany, OR Accepting Medicare
2 Podiatrists found. Showing 1 - 2
 Dr. Brian D Ashdown, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Willetta St Sw Ste D2, Albany, OR 97321 Phone: 541-928-3413 Fax: 877-437-6974 |
Dr. Scott Kenneth Rasmussen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 400 Hickory St Nw Ste 101, Albany, OR 97321 Phone: 541-812-3360 |
News Archive
Breast cancer: Lower dose of radiotherapy in fewer, larger doses as effective as higher total dose
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
Magnetic nanoparticles for cancer therapy
A measuring procedure developed in the Physikalisch-Technische Bundesanstalt (PTB) can help to investigate in some detail the behaviour of magnetic nanoparticles which are used for cancer therapy.
Groups call for mandatory flu vaccinations for health workers
USA Today: "The American Academy of Pediatrics plans to call for all health workers to get flu vaccinations, saying unvaccinated doctors, nurses and other medical staffers pose a threat to patients. The academy, which represents 60,000 pediatricians, is the latest of several organizations that now back mandatory flu shots for health workers
Study reveals new mechanism that may block formation of new blood vessels and cancer growth
A study led by researchers at Boston University School of Medicine demonstrates a new mechanism involving a signaling protein and its receptor that may block the formation of new blood vessels and cancer growth. The findings are published in the December issue of Science Signaling.
Researchers present Phase III study of neoadjuvant therapy with trastuzumab and lapatinib for early breast cancer
Researchers presented Phase III efficacy data from the GeparQuinto study, a head-to-head comparison of neoadjuvant lapatinib and trastuzumab in combination with chemotherapy for patients with early breast cancer, at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
› Verified 3 days ago
Physical Therapists
Speech-Language Pathologists
Optometrists
Chiropractors
Occupational Therapists
Podiatrists
Audiologists